Cypherpunk Secures $58.9M for Zcash Treasury as Stock Surges 25%
By ATTN Desk · Editorial oversight: Sean Han
Introduction
Cypherpunk Technologies Inc. (Nasdaq: CYPH), previously known as Leap Therapeutics, Inc., is a publicly traded company headquartered in Cambridge, Massachusetts. On November 13, 2025, the firm changed its name and ticker symbol to reflect a new digital asset treasury strategy focused on Zcash (ZEC), while continuing to develop its oncology pipeline.
Corporate Structure
Cypherpunk employs between 11 and 50 people, with expertise in biotechnology and blockchain services. Douglas E. Onsi serves as President and Chief Executive Officer. Effective November 11, 2025, Khing Oei was appointed Chairman of the Board, and Will McEvoy became the company’s first Chief Investment Officer and a Board member. Christopher Mirabelli, PhD, stepped down as Chairman but remains on the Board.
Zcash by Viktor Forgacs
Recent Developments
On November 12, 2025, Cypherpunk announced a $58.88 million private placement led by Winklevoss Capital to fund its Zcash accumulation strategy. The company utilized $50 million of those proceeds to acquire 203,775.27 ZEC at an average price of $245.37 per coin. Trading under the new ticker CYPH began on November 13.
On November 20, 2025, the company filed an 8-K (items 1.01 and 9.01) to report the rebranding and leadership changes. Subsequently, on November 21, 2025, Winklevoss Capital Fund, LLC filed a Schedule 13D/A disclosing beneficial ownership of 12,084,463 shares, representing 19.9 percent of the outstanding common stock. A further 8-K was filed on December 16, 2025, covering various corporate governance items.
Financial and Strategic Analysis
As of December 19, 2025, Cypherpunk’s share price closed at $1.17, reflecting a 25.12 percent increase on Nasdaq with a trading volume of 749,842 shares. According to Yahoo Finance data, the company’s market capitalization is approximately $166.6 million. Trailing twelve-month net income was reported at –$51.1 million, with diluted EPS of –$1.22. The company reported cash on hand totaling $9.7 million against debt equivalent to 1.4 percent of equity.
Strategically, Cypherpunk’s transition to a Zcash-denominated treasury is intended to address inflationary pressures in traditional finance and leverage privacy-preserving blockchain technology. The management emphasizes alignment with long-term, value-oriented investors.
Market Position and Industry Context
Cypherpunk operates at the intersection of biotechnology and digital assets but is primarily categorized within digital asset treasury companies. Its emphasis on Zcash—one of the early privacy coins utilizing zk-SNARK proofs—differentiates it from peers that primarily hold Bitcoin or Ethereum. Zcash’s fixed supply of 21 million coins and features of selective transparency support Cypherpunk’s goal to uphold self-sovereignty and financial privacy as blockchain adoption increases.
tl;dr
On November 12, 2025, Cypherpunk executed a $58.88 million private placement and purchased 203,775 ZEC to initiate its digital asset treasury. Trading under ticker CYPH since November 13, the stock rose 25.12 percent to $1.17 on December 19, 2025. Winklevoss Capital holds a 19.9 percent stake. The company plans an SEC-registered at-the-market equity offering of up to $200 million, positioning it for further Zcash acquisitions and potential balance-sheet expansion.